'Safe' Aids vaccine mutates to threat
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.AN EXPERIMENTAL Aids vaccine supposedly rendered safe by scientists has mutated into a virulent form, highlighting the dangers of using conventional vaccines against Aids.
Scientists at the Centre for Applied Microbiology Research at Porton Down, Wiltshire, found that an experiment with a prototype vaccine against monkey Aids showed how easily a supposedly safe vaccine can change into a dangerous form. Using a live monkey Aids virus as a vaccine, which had been 'attenuated' or crippled to make it harmless, they found that in one out of eight macaque monkeys in the experiment the virus repaired itself within 17 weeks of being injected into the animal.
The virus went on to make further repairs over the next 28 weeks until it became almost indistinguishable from the virus that causes Aids in monkeys. The scientists found that the virus 'vaccine' had replicated freely within the inoculated animal and had reverted to its dangerous form.
Live attenuated viruses are used as vaccines against infections ranging from measles to polio. Many Aids researchers believe they offer the best chance of a vaccine against Aids. Previous research on the simian immunodeficiency virus, SIV, showed it was possible to use live attenuated forms of the virus as a vaccine. Ronald Desrossier at the New England Regional Primate Research Centre near Boston, Massachusetts, found in December 1992 that attenuated SIV gave monkeys the best long-term protection against infection with the virulent forms of the virus.
After showing that monkeys inoculated with the vaccine could survive repeated injections of dangerous strains of SIV, Professor Desrossier proposed that human trials with an attenuated HIV vaccine should begin as soon as possible.
But Professor Jim Neil, an Aids researcher at Glasgow University, said the British research demonstrated the potential dangers of using live attenuated viruses as vaccines. A potential vaccine that proves to be safe under laboratory conditions may evolve into dangerous forms when used in the outside world, he added.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments